United N (2017) World Drug Report 2016. United Nations Office on Drugs and Crime, Vienna
Alam-Mehrjerdi Z, Abdollahi M, Higgs P, Dolan K (2015) Drug use treatment and harm reduction programs in Iran: a unique model of health in the most populated Persian Gulf country. Asian J Psychiatr 16:78–83
Ghane T, Zamani N, Hassanian-Moghaddam H, Beyrami A, Noroozi A (2018) Lead poisoning outbreak among opium users in the Islamic Republic of Iran, 2016–2017. Bull World Health Organ 96:165
Afzali S, Saleh AE, Seif RMA, Taheri K (2013) Frequency of alcohol and substance abuse observed in drivers killed in traffic accidents in Hamadan, Iran
Shiraly R, Taghva M (2018) Factors associated with sustained remission among chronic opioid users. Addict Health 10:86
Bonhomme J, Shim RS, Gooden R, Tysu D, Rust G (2012) Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options. J Natl Med Assoc 104:342–350
Rapeli P, Fabritius C, Kalska H, Alho H (2011) Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates. BMC Clin Pharmacol 11:1–16
Delorme J, Chenaf C, Kabore J-L, Pereira B, Mulliez A, Tremey A et al (2016) Incidence of high dosage buprenorphine and methadone shopping behavior in a retrospective cohort of opioid-maintained patients in France. Drug Alcohol Depend 162:99–106
Yilmaz U, Doksoz O, Celik T, Akinci G, Mese T, Yilmaz TS (2014) The value of neurologic and cardiologic assessment in breath holding spells. Pakistan J Med Sci 30:59
Afkhami AA (2009) From punishment to harm reduction: resecularization of addiction in contemporary Iran. Contemporary Iran: economy, society, politics, pp 194–210
Berjas F, Govari F, Mohammad AZS, Haghdoost AA (2011) The opinions of hospitalized addicts in Kerman rehabilitation centers about factors affecting their tendency toward drugs
Barnett PG, Rodgers JH, Bloch DA (2001) A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction 96:683–690
O’Connor AM, Cousins G, Durand L, Barry J, Boland F (2020) Retention of patients in opioid substitution treatment: a systematic review. PLoS One 15:e0232086
Mattick RP, Breen C, Kimber J, Davoli M (2014) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2(2)
Muller AE, Bjørnestad R, Clausen T (2018) Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications. Drug Alcohol Depend 187:22–28
Yee A, Danaee M, Loh HS, Sulaiman AH, Ng CG (2016) Sexual dysfunction in heroin dependents: a comparison between methadone and buprenorphine maintenance treatment. PLoS One 11:e0147852
Kaviani H, Seyfourian H, Sharifi V, Ebrahimkhani N (2009) Reliability and validity of Anxiety and Depression Hospital Scales (HADS): Iranian patients with anxiety and depression disorders. Tehran Univ Med J 67:379–385
Manavipour D (2015) Psychometric properties of the sleep questionnaire. Neurosci J Shefaye Khatam 3:15–20
Babazadeh S, Habibi M, Gohari-Derakhshande N (2020) Study of psychometric properties of the International Index of Erectile Function (IIEF) in substance dependent men. J Appl Psychol 14:457–435
Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF et al (2020) Opioid use disorder. Nat Rev Dis Primers 6:1–28
Chona K (2017) Methadone and its usage in treatment of opioid drug addiction
DiMario FJ Jr (2004) Increased QT dispersion in breath-holding spells. Acta Paediatr 93:728–733
Almasi A, Hajimoradi B, Mohammadi M (2019) Follow-up study of drug use, depression, and anxiety reduction and quality of life in addicts on methadone maintenance therapy. Jundishapur J Health Sci 11:1–6
Raeisi Z, Ghasab M, Golian S, Raeisi M, Chybakhsh S (2014) Effect of methadone on depression, anxiety and quality of life in addicts. J Ilam Univ Med Sci 22:132–139
Fatseas M, Auriacombe M (2007) Why buprenorphine is so successful in treating opiate addiction in France. Curr Psychiatry Rep 9:358–364
Le TA, Dang AD, Tran AHT, Nguyen LH, Nguyen THT, Phan HT et al (2019) Factors associated with sleep disorders among methadone-maintained drug users in Vietnam. Int J Environ Res Public Health 16:4315
Dunn KE, Finan PH, Tompkins DA, Strain EC (2018) Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients. Addict Behav 76:8–14
Hsu W-Y, Chiu N-Y, Liu J-T, Wang C-H, Chang T-G, Liao Y-C et al (2012) Sleep quality in heroin addicts under methadone maintenance treatment. Acta Neuropsychiatr 24:356–360
Li D-J, Chung K-S, Wu H-C, Hsu C-Y, Yen C-F (2018) Predictors of sleep disturbance in heroin users receiving methadone maintenance therapy: a naturalistic study in Taiwan. Neuropsychiatr Dis Treat 14:2853
Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213
Stein MD, Herman DS, Bishop S, Lassor JA, Weinstock M, Anthony J et al (2004) Sleep disturbances among methadone maintained patients. J Subst Abus Treat 26:175–180
Benca RM, Peterson MJ (2008) Insomnia and depression. Sleep Med 9:S3–S9
Han KS, Kim L, Shim I (2012) Stress and sleep disorder. Exp Neurobiol 21:141
Staner L (2010) Comorbidity of insomnia and depression. Sleep Med Rev 14:35–46
Paturi AK, Surani S, Ramar K (2011) Sleep among opioid users. Postgrad Med 123:80–87
Özkale Y, Erol İ, Özkale M (2018) Serum magnesium and calcium levels in children with breath-holding spells. Erciyes Med J/Erciyes Tip Dergisi 40
Hallinan R, Byrne A, Agho K, McMahon C, Tynan P, Attia J (2008) Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. J Sex Med 5:684–692
Yee A, Loh HS, Ng CG (2014) The prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments: a meta-analysis study. J Sex Med 11:22–32
Quaglio G, Lugoboni F, Pattaro C, Melara B, Mezzelani P, Des Jarlais DC (2008) Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. Drug Alcohol Depend 94:12–18
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Disclaimer:
This article is autogenerated using RSS feeds and has not been created or edited by OA JF.
Click here for Source link (https://www.springeropen.com/)
